Terms: = Gastric cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Treatment
14 results:
1. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
[No Abstract] [Full Text] [Related]
2. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
4. Identification of miR-4510 as a metastasis suppressor of gastric cancer through regulation of tumor microenvironment via targeting gpc3.
Ma HF; Shu P; Shi XH; Wang M; Jiang MF
Clin Exp Metastasis; 2022 Apr; 39(2):363-374. PubMed ID: 35050429
[TBL] [Abstract] [Full Text] [Related]
5. Both the serum AFP test and AFP/gpc3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract] [Full Text] [Related]
6. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in gastric cancer.
Zhao X; Zou J; Wang Z; Li G; Lei Y
Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
[TBL] [Abstract] [Full Text] [Related]
7. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Joharatnam-Hogan N; Cafferty F; Hubner R; Swinson D; Sothi S; Gupta K; Falk S; Patel K; Warner N; Kunene V; Rowley S; Khabra K; Underwood T; Jankowski J; Bridgewater J; Crossley A; Henson V; Berkman L; Gilbert D; Kynaston H; Ring A; Cameron D; Din F; Graham J; Iveson T; Adams R; Thomas A; Wilson R; Pramesh CS; Langley R;
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):854-862. PubMed ID: 31477558
[TBL] [Abstract] [Full Text] [Related]
8. Highly robust, uniform and ultra-sensitive surface-enhanced Raman scattering substrates for microRNA detection fabricated by using silver nanostructures grown in gold nanobowls.
Lee T; Wi JS; Oh A; Na HK; Lee J; Lee K; Lee TG; Haam S
Nanoscale; 2018 Feb; 10(8):3680-3687. PubMed ID: 29323386
[TBL] [Abstract] [Full Text] [Related]
9. Cronkhite-Canada syndrome associated with colon cancer metastatic to liver: A case report.
Wang J; Zhao L; Ma N; Che J; Li H; Cao B
Medicine (Baltimore); 2017 Sep; 96(38):e7466. PubMed ID: 28930817
[TBL] [Abstract] [Full Text] [Related]
10. DT-13, a saponin monomer of dwarf lilyturf tuber, induces autophagy and potentiates anti-cancer effect of nutrient deprivation.
Li H; Sun L; de Carvalho EL; Li X; Lv X; Khan GJ; Semukunzi H; Yuan S; Lin S
Eur J Pharmacol; 2016 Jun; 781():164-72. PubMed ID: 27079642
[TBL] [Abstract] [Full Text] [Related]
11. miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT.
Zhang D; Xiao YF; Zhang JW; Xie R; Hu CJ; Tang B; Wang SM; Wu YY; Hao NB; Yang SM
Cancer Lett; 2015 May; 360(2):151-9. PubMed ID: 25662441
[TBL] [Abstract] [Full Text] [Related]
12. Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.
Loupakis F; Masi G; Fornaro L; Vasile E; Allegrini G; Fontana E; Granetto C; Salvatore L; Mentuccia L; Andreuccetti M; Cortesi E; Merlano M; Cascinu S; Falcone A
Cancer Chemother Pharmacol; 2010 Aug; 66(3):559-66. PubMed ID: 20237927
[TBL] [Abstract] [Full Text] [Related]
13. Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans.
Dahele M; Skinner M; Schultz B; Cardoso M; Bell C; Ung YC
Med Dosim; 2010; 35(2):115-21. PubMed ID: 19931023
[TBL] [Abstract] [Full Text] [Related]
14. Molecular analysis of therapy resistance in gastric cancer.
Lage H
Dig Dis; 2003; 21(4):326-38. PubMed ID: 14752223
[TBL] [Abstract] [Full Text] [Related]
